Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Iris Pigment Epithelium (IPE) and IPE Regulatory T Cells Suppress Activation of T Cells via Membrane–Bound TGF–Beta

S. Sugita; Y. Futagami; S. Horie; M. Mochizuki; T.F. Ng; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5134. doi:

ARVO Annual Meeting Abstract May 2006

T Cell Suppression by Thrombospondin–1 on Pigment Epithelium (PE) and PE–Dependent Regulatory T Cells in the Eye

Y. Futagami; S. Sugita; S. Horie; J. Vega; K. Ishida; H. Aburatani; J.W. Streilein; M. Mochizuki

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5136. doi:

ARVO Annual Meeting Abstract May 2006

FOXP3+ CD25+ T Cells Induced by Ocular Pigment Epihelium Display Regulatory Phenotype and Aquire Regulatory Functions

S. Horie; S. Sugita; Y. Futagami; H. Keino; J.W. Streilein; M. Mochizuki

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5137. doi:

ARVO Annual Meeting Abstract May 2005

Increased Expression of an Inhibitor of NFkappaB, IkappaBalpha, in APCS Endows Them With the ACAID–Inducing Property

A.P. Ghafoori; B. Turpie; J.W. Streilein; S. Masli

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1045. doi:

ARVO Annual Meeting Abstract May 2005

Spontaneous Corneal Hem– and Lymphangiogenesis in Mice With Destrin–mutation Depend on VEGFR3–signaling

C. Cursiefen; S. Ikeda; A. Ikeda; J.–S. Mo; R. Dana; F.E. Kruse; B. Pytowski; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4495. doi:

ARVO Annual Meeting Abstract May 2005

Inflammation Induced Lymphangiogenesis in the Cornea Arises From Innate Immune Cells

K. Maruyama; M. Ii; C. Cursiefen; H. Keino; M. Tomita; D. Jackson; R. Dana; J.S. Streilein; D. Losordo; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4496. doi:

ARVO Annual Meeting Abstract May 2005

Inhibition of Angiogenesis and Lymphangiogenesis After High–Risk Keratoplasty by Neutralizing VEGF–A Improves Corneal Graft Survival

B.O. Bachmann; E. Lütjen–Drecoll; S.J. Wiegand; J.W. Streilein; F.E. Kruse; C. Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4743. doi:

ARVO Annual Meeting Abstract May 2005

Ocular Trauma Induced a Secondary Immunosuppressive Microenvironment Containing Active TGF–beta

J.S. Mo; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5044. doi:

ARVO Annual Meeting Abstract May 2004

Mutations in Gpnmb and Tryp1 are required for development of spontaneous anterior uveitis in DBA/2J mice with pigmentary glaucoma

J. Mo; M.G. Anderson; S.W. M. John; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):567. doi:

ARVO Annual Meeting Abstract May 2004

RPE Cells Use PEDF And MIF to Confer Innate Immune Privilege On The Subretinal Space

P. Zamiri; S. Masli; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):585. doi:

ARVO Annual Meeting Abstract May 2004

SEQUENTIAL TNFa AND GLUTATHIONE PEROXIDASE ACTIVATION IN ACAID–INDUCING, TGFb–TREATED APCS PREVENTS IL–12 PRODUCTION

S. Masli; B. Turpie; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):586. doi:

ARVO Annual Meeting Abstract May 2004

CTLA–4+ CD8+ T cells that encounter B7.2+ iris pigment epithelial cells express their own B7.2 to achieve global suppression of T cell activation

J. Schwartzkopff; S. Sugita; T.F. Ng; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):588. doi:

ARVO Annual Meeting Abstract May 2004

Inhibition of Hemangiogenesis and Lymphangiogenesis after Normal–Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

C. Cursiefen; L. Chen; K. Maruyama; D. Jackson; R. Dana; S. Wiegand; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):600. doi:

ARVO Annual Meeting Abstract May 2004

Local macrophage depletion improves survival of corneal xenografts in mice by blocking antigen presentation and inhibiting hem– and lymphangiogenesis.

L.P. Borges; C. Cursiefen; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):601. doi:

ARVO Annual Meeting Abstract May 2004

NOVEL EXPRESSION AND CHARACTERIZATION OF LYMPHATIC VESSEL ENDOTHELIAL HYALURONATE RECEPTOR (LYVE–1) BY OCULAR SURFACE CELLS.

L. Chen; C. Cursiefen; K. Maruyama; D. Jackson; Q. Zhang; J.W. Streilein; R. Dana

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):618. doi:

ARVO Annual Meeting Abstract May 2004

B7+ Iris Pigment Epithelial Cells Convert Naïve T Cells into CTLA–4+, B7–Expressing CD8+ Regulators

S. Sugita; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1009. doi:

ARVO Annual Meeting Abstract May 2004

Evidence that Regulator T cells of Eye–Derived Tolerance Can Arise from CD25–Negative Precursors

H. Keino; M. Takeuchi; T. Kezuka; T. Hattori; M. Usui; O. Taguchi; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2307. doi:

ARVO Annual Meeting Abstract May 2004

Corneal Hemangiogenesis And Lymphangiogenesis Immediately Following Penetrating Keratoplasty Are Triggered By Surgery Rather Than Alloimmunity

K. Maruyama; C. Cursiefen; D.G. Jackson; L. Chen; R. Dana; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2342. doi:

ARVO Annual Meeting Abstract May 2003

CD8+ Regulatory T Cells of ACAID Express Genes that Inhibit their Effector Functions, while Promoting their Regulatory Functions

H. Keino; S. Masli; B. Turpie; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1054. doi:

ARVO Annual Meeting Abstract May 2003

Role of Fas Ligand in the Activation of Macrophages by Corneal Endothelial Cells

J.M. Doherty; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):699. doi:

1 2

Next 20 Results »

Advertisement